أعرض في EDS

Initial results of BMS-986012, a first-in-class fucosyl-GM1 mAb, in combination with nivolumab, in pts with relapsed/refractory (rel/ref) small-cell lung cancer (SCLC)

التفاصيل البيبلوغرافية
العنوان:	Initial results of BMS-986012, a first-in-class fucosyl-GM1 mAb, in combination with nivolumab, in pts with relapsed/refractory (rel/ref) small-cell lung cancer (SCLC)
المؤلفون:	Georgia Kollia, K. Urbanska, S. Tannenbaum-Dvir, Stephen Clarke, C.M.L. van Herpen, G. Kolaitis, Deanne Lathers, Q.S-C. Chu, Daphne Williams, Neal Ready, Natasha B. Leighl, Ben Markman, C. Darby, P. Basciano, Rosalyn A. Juergens
المصدر:	Web of Science
مصطلحات موضوعية:	0301 basic medicine, business.industry, medicine.drug_class, Hematology, Monoclonal antibody, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Relapsed refractory, Cancer research, Medicine, Fucosyl GM1, Non small cell, Nivolumab, business
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4cec939479c65c49e02677b58f4942Test https://publons.com/wos-op/publon/18455203Test/
حقوق:	OPEN
رقم الانضمام:	edsair.doi.dedup.....be4cec939479c65c49e02677b58f4942
قاعدة البيانات:	OpenAIRE

الوصف
الوصف غير متاح.